Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S. Companies Doing Well In China; Express Concerns About Business Climate - Survey

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - Most U.S. companies in China are doing well and expect to expand operations this year, but bureaucracy and unclear laws and regulations are impeding their plans, the 2011 Business Climate Survey by the American Chamber of Commerce in the People's Republic of China shows

You may also be interested in...



Rising Labor Cost Top Risk For Multinationals In China – AmCham Survey

A slowing economy and regulatory uncertainty loom large for multinationals operating in China. However, companies say rising labor costs impact them more, and acute shortages of qualified employees further complicate the landscape.

European Companies Concerned About Regulatory Environment in China - European Chamber Of Commerce Survey

HONG KONG - The rule of law and transparent policy-making and implementation will be the most important factors in China's economic performance in the years ahead, a survey of European companies shows

European Companies Concerned About Regulatory Environment in China - European Chamber Of Commerce Survey

HONG KONG - The rule of law and transparent policy-making and implementation will be the most important factors in China's economic performance in the years ahead, a survey of European companies shows

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC077519

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel